Product Termination. King shall have the right to terminate Development and Marketing of a Product (the “Terminated Product”) hereunder by providing written notice to PTI [***] days prior to the effective date of such termination and, if necessary to comply with its obligations for maintaining a minimum number of Products, as provided in Section 3.1.3(a) above, designating a replacement Product in such notice, which shall be treated as a Product designation in accordance with Section 3.1.2 above, and the provisions of Section 9.2.2(a) shall apply to such Terminated Product in all respects. If a replacement Product is required to be designated, such notice of termination for such Terminated Product shall not be effective until a replacement Product has been selected and a Development Plan for such replacement Product has been approved by the JOC.
Product Termination. We may require you to close any of your positions which you may have with us and which may be or have been a!ected by product termination, no price provider or other relevant reasons, or we may close any of such positions at last available prices without prior notification at our sole discretion.
Product Termination. With Product End of Life (EOL) or termination of the CLIENT-D&K relationship, D&K shall use commercially reasonable efforts to minimize the CLIENT financial exposure of material in the supply chain pipeline. Efforts shall be made by D&K to understand what the lifetime buy requirements (if any) are, and only bring in that quantity of material sufficient to fulfill the PO. There will be a cessation of further orders to the vendor base, and cancellation of material no longer required.
Product Termination. In the event that the commercialization of one Product is terminated throughout Territory B by either BMS or Sanofi in accordance with Section 7.04 of the Alliance Support Agreement, then the Partners shall amend and restate this Agreement to delete any reference to the development, purchase, sale, marketing, promotion or commercialization of such Product.
Product Termination. 5.3.1 In the event that Alpharma fails to: (A) launch the Subsequent Product or Initial Product (considered individually) in the United States within **** months of completion of all activities (including, if required, receipt of Registration) required for the marketing of said Product therein, provided that such time period shall be extended by the delay caused by any event outside the control of Alpharma that directly delays any such Product launch; or (B) utilize Commercially Reasonable Efforts to market said Product within the United States and such failure continues for **** days after written notice thereof was provided to Alpharma by Tris (or, if such failure cannot be cured within such ****-day period, if Alpharma does not commence and diligently continue actions to cure such failure during such **** period), Tris shall have the right, in its sole discretion, to terminate the Commercialization Program and this Agreement with respect to such Product in the Territory, in accordance with Section 13.4.2.
Product Termination. In the event a Product Termination occurs for a Licensed Product outside the Territory, and in light of the cause of such Product Termination, it would not be reasonable for Licensee to continue development and commercialization of such Licensed Product in the Territory, or if a Product Suspension occurs under Section 14.2.5.1 then, in each case, Licensee shall have the right to terminate this Agreement with respect to such Licensed Product, upon thirty (30) days' prior written notice to Amgen (provided, however, that during such thirty (30) day period and such time as is reasonably necessary thereafter, Licensee shall provide any cooperation reasonably requested by Amgen to transition ongoing activities, and Amgen shall reimburse all reasonable, documented, out-of-pocket expenses incurred by Licensee in connection with the provision of such cooperation).
